with MASH-related cirrhosis, Child-Pugh class A, and model for end-stage liver disease scores ≤10. Among those, 62 underwent metabolic surgery (37 Roux-en-Y gastric bypass and 25 sleeve ...

In 62 patients who underwent bariatric surgery, the 15-year cumulative incidence of major adverse liver outcomes ...

The right-lobe liver biopsies were taken by laparotomy under general anaesthesia from 16 h-fasted minipigs during RYGB (n=7) and 4.5±1.5 weeks after the surgery, at the time of sacrifice (n=8).

Metabolic surgery significantly lowered risk for major adverse liver outcomes vs. nonsurgical management among patients with obesity and compensated cirrhosis ... Roux-en-Y gastric bypass (n ...

Purpose Pharmacokinetic considerations in patients who have undergone Roux-en-Y gastric bypass (RYGB ... circulation and are delivered to the liver for metabolism (first-pass metabolism) before ...

People with metabolic dysfunction-associated steatohepatitis (MASH), a severe form of fatty liver disease ... such as gastric sleeve or Roux-en-Y gastric bypass are such important options ...

Roux-en-Y gastric bypass is a weight loss surgery that makes your stomach smaller and reroutes your intestines. You feel full faster, so you eat less. It can also affect how you absorb calories and ...